Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm classically described as triphasic disease: chronic, accelerated, and blast crisis. There are many unmet needs and unanswered questions about CML. Intermittent fasting in patients with CML on tyrosine kinase inhibitors is among these un...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2020-06-01
|
| Series: | Case Reports in Oncology |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/507508 |
| _version_ | 1811221672825454592 |
|---|---|
| author | Husam N. Al-Dubai Mohammed A. Yassin Mohammed A. Abdulla Mahmood S. Aldapt Rola S. Ghassoub |
| author_facet | Husam N. Al-Dubai Mohammed A. Yassin Mohammed A. Abdulla Mahmood S. Aldapt Rola S. Ghassoub |
| author_sort | Husam N. Al-Dubai |
| collection | DOAJ |
| description | Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm classically described as triphasic disease: chronic, accelerated, and blast crisis. There are many unmet needs and unanswered questions about CML. Intermittent fasting in patients with CML on tyrosine kinase inhibitors is among these unmet needs. Here we report the effect of intermittent fasting on response to nilotinib as upfront in a 49-year-old female Muslim who fasted during Ramadan and took her medication once instead of twice daily and remained in major molecular response. |
| first_indexed | 2024-04-12T08:03:40Z |
| format | Article |
| id | doaj.art-9b4a2c8462784313af0e13da16c381a4 |
| institution | Directory Open Access Journal |
| issn | 1662-6575 |
| language | English |
| last_indexed | 2024-04-12T08:03:40Z |
| publishDate | 2020-06-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Case Reports in Oncology |
| spelling | doaj.art-9b4a2c8462784313af0e13da16c381a42022-12-22T03:41:14ZengKarger PublishersCase Reports in Oncology1662-65752020-06-0113266466710.1159/000507508507508Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as UpfrontHusam N. Al-DubaiMohammed A. YassinMohammed A. AbdullaMahmood S. AldaptRola S. GhassoubChronic myeloid leukemia (CML) is a myeloproliferative neoplasm classically described as triphasic disease: chronic, accelerated, and blast crisis. There are many unmet needs and unanswered questions about CML. Intermittent fasting in patients with CML on tyrosine kinase inhibitors is among these unmet needs. Here we report the effect of intermittent fasting on response to nilotinib as upfront in a 49-year-old female Muslim who fasted during Ramadan and took her medication once instead of twice daily and remained in major molecular response.https://www.karger.com/Article/FullText/507508fastingramadanchronic myeloid leukemianilotinib |
| spellingShingle | Husam N. Al-Dubai Mohammed A. Yassin Mohammed A. Abdulla Mahmood S. Aldapt Rola S. Ghassoub Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront Case Reports in Oncology fasting ramadan chronic myeloid leukemia nilotinib |
| title | Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront |
| title_full | Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront |
| title_fullStr | Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront |
| title_full_unstemmed | Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront |
| title_short | Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront |
| title_sort | ramadan fasting in a patient with chronic myeloid leukemia receiving nilotinib as upfront |
| topic | fasting ramadan chronic myeloid leukemia nilotinib |
| url | https://www.karger.com/Article/FullText/507508 |
| work_keys_str_mv | AT husamnaldubai ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront AT mohammedayassin ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront AT mohammedaabdulla ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront AT mahmoodsaldapt ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront AT rolasghassoub ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront |